+216 98 414 314
Properties of: Bortezomib
Formula:
C19H25BN4O4
CAS Number:
179324-69-7
Overview
Bortezomib is a medication classified as a proteasome inhibitor and is primarily used in the treatment of multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It may also be used in the treatment of certain types of lymphomas.